CROSBY Research – China Lesso (2128 HK/BUY): The emergence of new growth engine
21 Mar 2023 China Lesso’s FY22 turnover decreased by 4.0% YoY to Rmb30.8bn while NP ...
CROSBY Research – China Lilang (1234 HK): Expects at least 10% retail sales growth in FY23
21 Mar 2023 The company reported a 8.7% YoY decline in topline to Rmb3,086m in ...
CROSBY Research – Q-Tech Group (1478 HK/BUY): Automotive and IoT business become main growth driver, maintain BUY rating
20 Mar 2023 Q-Tech reported 2H22 revenue of Rmb6,664m, which decreased 28.5% YoY. 2H22 total ...
CROSBY Research – Stella International (1836 HK): Ramping up its capacity in the coming 3 years
20 Mar 2023 Stella’s FY22 revenue was up by 5.9% YoY to US$1,631m, mainly driven ...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 31)
13 Mar 2023 While the collapse in SVB will unlikely trigger another financial crisis, it ...
CROSBY Research – Concord New Energy (182 HK/BUY): Bodes well into the grid parity era
08 Mar 2023 CNE’s FY22 revenue was up by 22.0% YoY to Rmb2,679m, mainly due ...
CROSBY Research – Pentamaster International (1665 HK/BUY): Order book surged in 4Q22 driven by strong automotive and medical devices demand
02 Mar 2023 Pentamaster’s 4Q22 revenue increased 20.6% YoY from MYR122.4m in 4Q21 to MYR147.7m. ...
CROSBY Research – SIIC Environment (807 HK): Further expansion in GBA & YREB regions
01 Mar 2023 SIIC reported its FY22 result with an increase in revenue by 14.3% ...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 30)
27 Feb 2023 Christopher Hui, secretary for HKSAR financial services and the treasury, said on ...
CROSBY Research – Vincent Medical (1612 HK/Neutral): Weak respiratory sales and inventory pile-up dented bottom line
14 Feb 2023 Vincent Medical (VM) issued a profit warning citing that its FY22 reported ...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 29)
13 Feb 2023 The Chinese medical device market is one of opportunities. It is both ...
CROSBY Research – Nagacorp (3918 HK): Recovering from the pandemic
10 Feb 2023 Naga’s FY22 revenue was up by 104% YoY to US$461m, mainly driven ...
CROSBY Research – Vinda International (3331 HK): The worst should be over
31 Jan 2023 Vinda announced FY22 results, with revenue increased by 8.1% YoY to HK$19.4bn, ...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 28)
30 Jan 2023 A total of 484,505 tourists entered Macau during CNY this year, which ...
CROSBY Research – Xtep International (1368 HK/BUY): The worst has passed, a year of recovery in 2023
19 Jan 2023 Xtep reported its 4Q22 operational data with retail sell-through (including both online ...
CROSBY Research – China Everbright Greentech (1257 HK/BUY): FY22 results preview
13 Jan 2023 CEG’s 1H22 revenue edged down by 2% YoY to HK$4,220m, and 1H22NP ...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 27)
09 Jan 2023 HK/China border fully reopened on 8th Jan 2023. Sun Hung Kai Properties ...
CROSBY Research – Channel Micron (2115 HK/BUY): Key beneficiary of China’s massive semiconductor factory buildout and international enterprises investment trends in Southeast AsiaCROSBY Research
06 Jan 2023 Channel Micron is a leading cleanroom system provider based in China and ...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 26) – Feature Article: Renewable Energy – Demand for distributed wind power on the rise
05 Dec 2022 Decentralized wind power is becoming a new growth point in the wind ...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 25)
22 Nov 2022 Hong Kong unemployment rate dropped slightly from 3.9% (May to Jul) to ...